247 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
include the name of the target (or targets) or a summary description of the assets to be acquired and shall confirm that the aggregate purchase … of any Sanctions, (ii) included on OFAC’s List of Specially Designated Nationals or HMT’s Consolidated List of Financial Sanctions Targets, or any
425
151yjs8kbhl1 aj
3 Oct 22
Business combination disclosure
9:20am
8-K
EX-99.1
p19frld h40g4sso
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
425
j6cs 25y3trd3r
24 Aug 22
Business combination disclosure
5:21pm
8-K
EX-99.1
idam4qgzim
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
6wy728q6mm3
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
ydlblntxtx 9jdt
21 Jun 22
Regulation FD Disclosure
6:19am
425
kmx77so fg0b1r
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
fb6twst
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
kc5b17
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.1
mgslxgvv m2ayarj6
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
iaxt jenv1rcl6jjm
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.2
kx3z5c4dh8h9
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.3
tkucmtyvjiykkn
23 Mar 22
Business combination disclosure
5:29pm